HAVCR2 and melanoma: This observation aligns with that in functional studies of melanoma, where YY1 was found to positively regulate immune checkpoint receptors, such as PD-1, LAG3, and TIM-3, while suppressing type I cytokines IL-2 and IFN-γ, promoting T-cell exhaustion and immune evasion [38].